Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia

Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia

We explored the feasibility of collecting convalescent plasma for passive immunotherapy of Middle East respiratory syndrome coronavirus (MERS-CoV) infection by using ELISA to screen serum samples from 443 potential plasma donors: 196 patients with suspected or laboratory-confirmed MERS-CoV infection...

Full description

Bibliographic Details
Main Authors: Yaseen M. Arabi, Ali H. Hajeer, Thomas Luke, Kanakatte Raviprakash, Hanan Balkhy, Sameera Johani, Abdulaziz Al-Dawood, Saad Al-Qahtani, Awad Al-Omari, Fahad Al-Hameed, Frederick G. Hayden, Robert Fowler, Abderrezak Bouchama, Nahoko Shindo, Khalid Al-Khairy, Gail Carson, Yusri Taha, Musharaf Sadat, Mashail Alahmadi
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2016-09-01
Series:Emerging Infectious Diseases
Subjects:
Middle East respiratory syndrome coronavirus
MERS-CoV
Middle East respiratory syndrome
intensive care
convalescent plasma
high-titer convalescent plasma
Online Access:https://wwwnc.cdc.gov/eid/article/22/9/15-1164_article

Internet

https://wwwnc.cdc.gov/eid/article/22/9/15-1164_article

Similar Items